Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma.
about
Molecular genetics of peripheral T-cell lymphomas.Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway.
P2860
Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma.
@en
Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma.
@nl
type
label
Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma.
@en
Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma.
@nl
prefLabel
Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma.
@en
Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma.
@nl
P2860
P356
P1433
P1476
Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma.
@en
P2860
P2888
P356
10.1038/LEU.2012.304
P577
2013-04-01T00:00:00Z
P5875
P6179
1009471465